176 related articles for article (PubMed ID: 11849769)
1. The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease.
Mattila P; Togo T; Dickson DW
Neurosci Lett; 2002 Mar; 320(1-2):81-5. PubMed ID: 11849769
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.
Fujino Y; Wang DS; Thomas N; Espinoza M; Davies P; Dickson DW
J Neuropathol Exp Neurol; 2005 Mar; 64(3):209-14. PubMed ID: 15804052
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Botez G; Probst A; Ipsen S; Tolnay M
Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
[TBL] [Abstract][Full Text] [Related]
4. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
[TBL] [Abstract][Full Text] [Related]
5. Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies.
Ishizawa T; Ko LW; Cookson N; Davias P; Espinoza M; Dickson DW
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1040-7. PubMed ID: 12484566
[TBL] [Abstract][Full Text] [Related]
6. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
8. Argyrophilic grain pathology as a natural model of tau propagation.
Rábano A; Rodal I; Cuadros R; Calero M; Hernández F; Ávila J
J Alzheimers Dis; 2014; 40 Suppl 1():S123-33. PubMed ID: 24577470
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic grain disease: frequency and neuropathology in centenarians.
Ding ZT; Wang Y; Jiang YP; Yoshida M; Mimuro M; Inagaki T; Iwase T; Hashizume Y
Acta Neuropathol; 2006 Apr; 111(4):320-8. PubMed ID: 16525805
[TBL] [Abstract][Full Text] [Related]
10. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease.
Fujishiro H; Uchikado H; Arai T; Hasegawa M; Akiyama H; Yokota O; Tsuchiya K; Togo T; Iseki E; Hirayasu Y
Acta Neuropathol; 2009 Feb; 117(2):151-8. PubMed ID: 19039597
[TBL] [Abstract][Full Text] [Related]
12. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
13. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
[TBL] [Abstract][Full Text] [Related]
14. Tau accumulation in a patient with pallidonigroluysian atrophy.
Mori H; Motoi Y; Kobayashi T; Hasegawa M; Yamamura A; Iwatsubo T; Mizuno Y
Neurosci Lett; 2001 Aug; 309(2):89-92. PubMed ID: 11502352
[TBL] [Abstract][Full Text] [Related]
15. [Argyrophilic grain disease (AgD), a frequent and largely underestimated cause of dementia in old patients].
Probst A; Tolnay M
Rev Neurol (Paris); 2002 Feb; 158(2):155-65. PubMed ID: 11965171
[TBL] [Abstract][Full Text] [Related]
16. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
[TBL] [Abstract][Full Text] [Related]
17. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology.
Thal DR; Schultz C; Botez G; Del Tredici K; Mrak RE; Griffin WS; Wiestler OD; Braak H; Ghebremedhin E
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):270-9. PubMed ID: 15885064
[TBL] [Abstract][Full Text] [Related]
18. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
19. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
[TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Development of Neuronal and Astrocytic Tau Pathologies in Subcortical Nuclei and Progression of Argyrophilic Grain Disease.
Ikeda C; Yokota O; Nagao S; Ishizu H; Oshima E; Hasegawa M; Okahisa Y; Terada S; Yamada N
Brain Pathol; 2016 Jul; 26(4):488-505. PubMed ID: 26439704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
